Tryngolza is the brand name for Ingolzic, the first FDA approved treatment for Familial Chylomicronemia Syndrome (FCS) a rare, life-threatening condition that causes uncontrolled triglyceride levels. The campaign needed to convey two distinct patient journeys while capturing the emotional weight of finally having a treatment that works.

Our role was to produce a mixed-media campaign combining live-action photography, 3D CGI, and post-production compositing. Two characters: a woman representing a clinically diagnosed patient, and a man representing a genetically positive patient were photographed on seamless in our Barcelona studio.